This metabolite includes a PDE selectivity profile comparable to sildenafil and an in vitro potency for PDE5 about fifty% with the guardian drug. Plasma concentrations of this metabolite are approximately 40% of Individuals viewed for sildenafil, so which the metabolite accounts for about 20% of sil